Your browser is no longer supported. Please, upgrade your browser.
NNVC [AMEX]
NanoViricides, Inc.
Index- P/E- EPS (ttm)-0.86 Insider Own9.73% Shs Outstand10.95M Perf Week-4.13%
Market Cap49.49M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float10.39M Perf Month-10.49%
Income-8.60M PEG- EPS next Q- Inst Own8.80% Short Float6.92% Perf Quarter-0.24%
Sales- P/S- EPS this Y-2.00% Inst Trans1.96% Short Ratio2.07 Perf Half Y11.47%
Book/sh2.91 P/B1.44 EPS next Y- ROA-29.60% Target Price- Perf Year-36.28%
Cash/sh1.93 P/C2.16 EPS next 5Y- ROE-31.00% 52W Range2.85 - 8.71 Perf YTD45.64%
Dividend- P/FCF- EPS past 5Y-25.20% ROI- 52W High-50.98% Beta0.83
Dividend %- Quick Ratio26.70 Sales past 5Y- Gross Margin- 52W Low49.82% ATR0.44
Employees17 Current Ratio26.70 Sales Q/Q- Oper. Margin- RSI (14)50.38 Volatility13.46% 9.23%
OptionableYes Debt/Eq0.01 EPS Q/Q84.50% Profit Margin- Rel Volume3.16 Prev Close4.18
ShortableYes LT Debt/Eq0.00 Earnings- Payout- Avg Volume347.36K Price4.27
Recom1.00 SMA201.24% SMA504.62% SMA2004.59% Volume576,886 Change2.15%
Feb-11-15Initiated Midtown Partners Strong Buy $5.30
Jun-28-21 08:28AM  
Jun-22-21 12:49PM  
May-17-21 06:45AM  
Mar-09-21 08:08AM  
05:45AM  
Mar-02-21 08:01AM  
06:15AM  
04:43AM  
Feb-18-21 04:59AM  
Feb-17-21 06:15AM  
Feb-08-21 07:40AM  
06:15AM  
Jan-27-21 06:15AM  
Nov-19-20 06:20AM  
Nov-18-20 11:49AM  
Nov-17-20 06:20AM  
Nov-11-20 10:55AM  
06:20AM  
Oct-15-20 06:15AM  
Sep-18-20 05:35PM  
Sep-16-20 06:15AM  
Sep-08-20 09:10AM  
Sep-04-20 06:50AM  
Sep-02-20 06:15AM  
Aug-31-20 05:00PM  
08:40AM  
Aug-06-20 01:43PM  
Jul-23-20 11:48AM  
Jul-21-20 06:15AM  
Jul-20-20 06:10PM  
Jul-16-20 03:16PM  
10:52AM  
Jul-13-20 06:30AM  
Jul-09-20 06:15AM  
Jul-08-20 05:55PM  
05:50PM  
06:15AM  
Jun-30-20 06:15AM  
Jun-25-20 11:05AM  
Jun-23-20 06:15AM  
Jun-09-20 07:46AM  
06:15AM  
May-26-20 06:15AM  
May-21-20 08:30AM  
May-20-20 06:15AM  
May-18-20 06:15AM  
May-13-20 10:12AM  
May-12-20 12:57PM  
06:15AM  
May-04-20 06:15AM  
Apr-29-20 06:15AM  
Apr-21-20 02:00PM  
Apr-13-20 06:15AM  
Apr-07-20 02:31PM  
11:49AM  
Apr-06-20 06:15AM  
Mar-31-20 07:30AM  
Mar-16-20 06:15AM  
Mar-14-20 10:18AM  
Mar-13-20 05:42PM  
Mar-09-20 02:44PM  
Mar-05-20 04:11PM  
Feb-28-20 04:57PM  
Feb-25-20 03:25PM  
Feb-24-20 08:39AM  
08:04AM  
06:15AM  
Feb-18-20 01:01PM  
Feb-12-20 06:15AM  
Feb-10-20 07:30AM  
Feb-06-20 05:50PM  
Feb-04-20 07:30AM  
Feb-03-20 02:17PM  
08:59AM  
Feb-01-20 10:53AM  
Jan-31-20 09:09AM  
Jan-30-20 06:20PM  
10:54AM  
Jan-28-20 02:23PM  
07:53AM  
Jan-27-20 04:29PM  
04:03PM  
02:21PM  
10:58AM  
08:43AM  
Jan-24-20 10:45PM  
03:08PM  
Jan-23-20 03:14PM  
01:02PM  
11:01AM  
10:18AM  
09:51AM  
06:54AM  
Jan-22-20 09:09AM  
08:12AM  
Jan-21-20 08:35PM  
02:40PM  
Jan-09-20 08:00AM  
Jan-07-20 08:30AM  
Jan-06-20 07:30AM  
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut.